By SPC News Staff
Computational approaches to selecting combinations of broadly neutralizing antibodies (bNAbs) based on viral genetics could help prevent viral escape, making HIV treatment more effective, and could offer a strategy for designing effective combinations of treatment for other pathogens, as well, scientists said (eLife 2022 Jul 19. doi:10.7554/eLife.76004).
“Our study shows that leveraging genetic data can help us design more effective HIV therapies,” said Armita